Details:

Alternative Title:
Malar J
Publisher's site:
http://dx.doi.org/10.1186/s12936-015-0950-6
Personal Author:
Dellicour, Stephanie ; Desai, Meghna ; Aol, George ; Oneko, Martina ; Ouma, Peter ; ... More +
Dellicour, Stephanie ; Desai, Meghna ; Aol, George ; Oneko, Martina ; Ouma, Peter ; Bigogo, Godfrey ; Burton, Deron C. ; Breiman, Robert F. ; Hamel, Mary J. ; Slutsker, Laurence ; Feikin, Daniel ; Kariuki, Simon ; Odhiambo, Frank ; Pandit, Jayesh ; Laserson, Kayla F. ; Calip, Greg ; Stergachis, Andy ; ter Kuile, Feiko O. Less -
Description:
Background

The artemisinin anti-malarials are widely deployed as artemisinin-based combination therapy (ACT). However, they are not recommended for uncomplicated malaria during the first trimester because safety data from humans are scarce.

Methods

This was a prospective cohort study of women of child-bearing age carried out in 2011–2013, evaluating the relationship between inadvertent ACT exposure during first trimester and miscarriage. Community-based surveillance was used to identify 1134 early pregnancies. Cox proportional hazard models with left truncation were used.

Results

The risk of miscarriage among pregnancies exposed to ACT (confirmed + unconfirmed) in the first trimester, or during the embryo-sensitive period (≥6 to <13 weeks gestation) was higher than among pregnancies unexposed to anti-malarials in the first trimester: hazard ratio (HR) = 1.70, 95 % CI (1.08–2.68) and HR = 1.61 (0.96–2.70). For confirmed ACT-exposures (primary analysis) the corresponding values were: HR = 1.24 (0.56–2.74) and HR = 0.73 (0.19–2.82) relative to unexposed women, and HR = 0.99 (0.12–8.33) and HR = 0.32 (0.03–3.61) relative to quinine exposure, but the numbers of quinine exposures were very small.

Conclusion

ACT exposure in early pregnancy was more common than quinine exposure. Confirmed inadvertent artemisinin exposure during the potential embryo-sensitive period was not associated with increased risk of miscarriage. Confirmatory studies are needed to rule out a smaller than three-fold increase in risk.

Electronic supplementary material

The online version of this article (doi:10.1186/s12936-015-0950-6) contains supplementary material, which is available to authorized users.


Subject:
[+]
Anti-malarials Drug Safety In Pregnancy Miscarriage Pharmacovigilance Research Teratogenicity
Source:
Malar J. 14.
Pubmed ID:
26581434
Pubmed Central ID:
PMC4652370
Document Type:
Journal Article
Collection(s):
CDC Public Access
Main Document Checksum:
[+]
urn:sha256:c45b14108a1138c02911335cea17684faf14a6ed633f07e938eabaac28320cab
Download URL:
https://stacks.cdc.gov/view/cdc/35769/cdc_35769_DS1.pdf
File Type:

Supporting Files

• 	12936_2015_950_MOESM3_ESM.docx	docx
  	12936_2015_Article_950.nxml	bin
  	license.txt	txt
  	12936_2015_950_Fig1_HTML.gif	gif
  	12936_2015_950_Fig1_HTML.jpg	jpeg
  	12936_2015_950_Fig2_HTML.gif	gif
  	12936_2015_950_Fig2_HTML.jpg	jpeg
  	12936_2015_950_MOESM1_ESM.docx	docx
  	12936_2015_950_MOESM2_ESM.docx	docx

More +